Affiliated Managers Group, Inc. (AMG) Latest News

NYSE Currency in USD Disclaimer

Add to Alerts ADD TO LIST

$243.11

north_east

$6.56 (2.77%)

Day's range

$237.26

$243.82

Latest News of AMG

Amgen's Imdylltra wins conditional MHRA licence for lung cancer

Amgen's Imdylltra wins conditional MHRA licence for lung cancer

By Yahoo! Finance | 11 months ago

Horos Asset Management Trimmed Affiliated Managers Group (AMG) Following Strong Performance

Horos Asset Management Trimmed Affiliated Managers Group (AMG) Following Strong Performance

By Yahoo! Finance | 11 months ago

Why Amgen Inc. (AMGN) Is Among the Best Affordable Stocks to Buy Right Now

Why Amgen Inc. (AMGN) Is Among the Best Affordable Stocks to Buy Right Now

By Yahoo! Finance | 1 year ago

Healthy Returns: Wall Street mulls over Amgen's weight loss drug data

Healthy Returns: Wall Street mulls over Amgen's weight loss drug data

By CNBC | 1 year ago

Holidazed's Loretta Devine Says a Boyfriend During Her 'Dreamgirls' Days 'Got My Mother High by Accident' When They First Met (Exclusive)

Holidazed's Loretta Devine Says a Boyfriend During Her 'Dreamgirls' Days 'Got My Mother High by Accident' When They First Met (Exclusive)

By PEOPLE.com | 1 year ago

Why IAMGOLD Corporation (IAG) is One of the Best Canadian Stocks to Buy Under $10?

Why IAMGOLD Corporation (IAG) is One of the Best Canadian Stocks to Buy Under $10?

By Yahoo! Finance | 1 year ago

Amgen drug delivers more weight loss than competitors

Amgen drug delivers more weight loss than competitors

By Newsweek | 1 year ago

What's next for Amgen obesity drug after investors disappointed by results

What's next for Amgen obesity drug after investors disappointed by results

By Newsweek | 1 year ago

Amgen Falls as Weight-Loss Shot Results Disappoint Street

Amgen Falls as Weight-Loss Shot Results Disappoint Street

By Yahoo! Finance | 1 year ago

New Amgen Drug MariTide Shows Promising Weight Loss in Early Data

New Amgen Drug MariTide Shows Promising Weight Loss in Early Data

By The New York Times | 1 year ago

Amgen Stock Dives Despite Positive Maritide Weight-Loss Drug Data. What to Know.

Amgen Stock Dives Despite Positive Maritide Weight-Loss Drug Data. What to Know.

By MarketWatch | 1 year ago

Amgen Crashes 12% After Obesity Drug Meets Lilly's In A Key Test

Amgen Crashes 12% After Obesity Drug Meets Lilly's In A Key Test

By Investor's Business Daily | 1 year ago

Amgen Reveals Data From Closely Watched Monthly Obesity Drug, With Weight Loss Of Up To 20% At One Year And No Plateau

Amgen Reveals Data From Closely Watched Monthly Obesity Drug, With Weight Loss Of Up To 20% At One Year And No Plateau

By Yahoo! Finance | 1 year ago

Amgen's stock slides 7.8% premarket after weight-loss drug data lags analyst expectations

Amgen's stock slides 7.8% premarket after weight-loss drug data lags analyst expectations

By MarketWatch | 1 year ago

Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau

Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau

By CNBC | 1 year ago